Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dinogest versus mifepristone for adenomyosis
ChiCTR2000031656Phase 4Not yet recruiting
- Sponsor
- Women's Hospital, School of Medicine, Zhejiang University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dienogest, mifepristone and gonadotropin-releasing hormone agonist in adenomyosis (4 arms), sponsored by Women's Hospital, School of Medicine, Zhejiang University. Primary endpoints: Pain score, Change of menstrual volume and 6 more. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
dienogestmifepristonegonadotropin-releasing hormone agonist
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ChiCTR2000031656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031656.